Sunday, 28 October 2018
Cancer Is One Of The Most Expensive Disease, And It Is Becoming More And More Expensive
Cancer Is One Of The Most Expensive Disease, And It Is Becoming More And More Expensive.
Millions of Americans with a old hat of cancer, markedly subjects under age 65, are delaying or skimping on medical care because of worries about the back of treatment, a new study suggests. The finding raises troubling questions about the long-term survival and characteristic of life of the 12 million adults in the United States whose lives have been forever changed by a diagnosis of cancer toe nail fungus ottamooli. "I consider it's concerning because we recognize that cancer survivors have many medical needs that on for years after their diagnosis and treatment," said study lead inventor Kathryn E Weaver, an assistant professor in the Department of Social Sciences & Health Policy at Wake Forest University Baptist Medical Center in Winston-Salem, NC.
The communication was published online June 14 in Cancer, a tabloid of the American Cancer Society. Cost concerns have posed a forewarning to cancer survivorship for some time, particularly with the advent of new, life-prolonging treatments. Dr Patricia Ganz, a professor in the Department of Health Services at the University of California, Los Angeles School of Public Health, served on the Institute of Medicine council that wrote the 2005 report, From Cancer Patient to Cancer Survivor: Lost in Transition erectile dysfunction. "One of the things that we remarkably emphasized was want of insurance, uniquely for follow-up care".
CancerCare, a New York City-based nonprofit succour group for cancer patients, provides co-payment assistance for set cancer medications. "Cancer is a vey expensive disease and it's becoming more and more expensive," said Jeanie M Barnett, CancerCare's big cheese of communications. "The costs of the drugs are prevailing up. So, too, is the proportion that the patient pays out of pocket".
A March 17 commentary in the Journal of the American Medical Association, titled "Cancer's Next Frontier - Addressing High and Increasing Costs," reported that the run costs of cancer had swelled from $27 billion in 1990 to more than $90 billion in 2008.
Millions of Americans with a old hat of cancer, markedly subjects under age 65, are delaying or skimping on medical care because of worries about the back of treatment, a new study suggests. The finding raises troubling questions about the long-term survival and characteristic of life of the 12 million adults in the United States whose lives have been forever changed by a diagnosis of cancer toe nail fungus ottamooli. "I consider it's concerning because we recognize that cancer survivors have many medical needs that on for years after their diagnosis and treatment," said study lead inventor Kathryn E Weaver, an assistant professor in the Department of Social Sciences & Health Policy at Wake Forest University Baptist Medical Center in Winston-Salem, NC.
The communication was published online June 14 in Cancer, a tabloid of the American Cancer Society. Cost concerns have posed a forewarning to cancer survivorship for some time, particularly with the advent of new, life-prolonging treatments. Dr Patricia Ganz, a professor in the Department of Health Services at the University of California, Los Angeles School of Public Health, served on the Institute of Medicine council that wrote the 2005 report, From Cancer Patient to Cancer Survivor: Lost in Transition erectile dysfunction. "One of the things that we remarkably emphasized was want of insurance, uniquely for follow-up care".
CancerCare, a New York City-based nonprofit succour group for cancer patients, provides co-payment assistance for set cancer medications. "Cancer is a vey expensive disease and it's becoming more and more expensive," said Jeanie M Barnett, CancerCare's big cheese of communications. "The costs of the drugs are prevailing up. So, too, is the proportion that the patient pays out of pocket".
A March 17 commentary in the Journal of the American Medical Association, titled "Cancer's Next Frontier - Addressing High and Increasing Costs," reported that the run costs of cancer had swelled from $27 billion in 1990 to more than $90 billion in 2008.
Subscribe to:
Posts (Atom)